High D‐index during mobilization predicts poor mobilization of CD34+ cells after anti‐lymphoma salvage chemotherapy
High D‐index during mobilization predicts poor mobilization of CD34+ cells after anti‐lymphoma salvage chemotherapy
复制标题
动员期间高 D 指数预示抗淋巴瘤挽救化疗后 CD34+ 细胞动员不良
DOI:
10.1002/jca.21943
复制
发表时间:
2021
影响因子:
1.5
通讯作者:
Kurokawa Mineo
中科院分区:
文献类型:
--
作者:
Ebisawa Kazutoshi;Honda Akira;Chiba Akira;Masamoto Yosuke;Okazaki Hitoshi;Kurokawa Mineo
BackgroundPerforming stem cell collection after mobilization chemotherapy was a well‐balanced strategy between anti‐tumor effect and efficient collection of CD34+ cells, but deep and prolonged nadir exposed patients to risk of febrile neutropenia. Febrile neutropenia was known to be associated with lower yields of CD34+ cells, but quantitative data referring to association between yields of CD34+ cells and severity of neutropenia was lacking. We hypothesized that D‐index, which was developed for quantitative evaluation of severity of neutropenia especially in the field of hematologic malignancies, could predict yields of CD34+ cells.MethodsWe performed a single center, retrospective analysis of patients with relapsed or refractory aggressive lymphoma who were mobilized with ESHAP or modified ESHAP. We evaluated the association between yields of CD34+ cells at first apheresis and D‐index.ResultsThirty‐six patients were included, and we demonstrated that yields of CD34+ cells from patients with higher D‐index were significantly lower than those from patients with lower D‐index. Multivariate linear regression analysis and logistic regression analysis also demonstrated the significant predictive power of D‐index. Further, D‐index was significantly correlated to platelet count before starting mobilization chemotherapy. Platelet count was known to predict yields of CD34+ cells, and combination of platelet count and D‐index could identify patients with lowest CD34+ yields.ConclusionD‐index could predict yields of CD34+ cells and it seemed that its predictive power was not less than that of platelet count. Prospective studies including more heterogeneous patients were needed to validate our study.
登录
查看更多内容
影响因子:
1.5
作者:
E. Jantunen;A. Partanen;J. Valtola;M. Pyörälä;P. Mäntymaa;T. Nousiainen;V. Varmavuo
通讯作者:
V. Varmavuo
影响因子:
1.5
作者:
Tanaka, Hiroaki;Ishii, Akihiro;Kakuta, Shinichiro
通讯作者:
Kakuta, Shinichiro
影响因子:
1.5
作者:
C. Couzin;S. Manceau;J. Diana;L. Joseph;A. Magnani;E. Magrin;Horiya Amrane;Emilie Dupont;J. Raphalen;D. Sibon;A. Marçais;F. Suarez;M. Cavazzana;F. Lefrère;Marianne Delville
通讯作者:
Marianne Delville
影响因子:
4.5
作者:
Sancho, Juan-Manuel;Morgades, Mireia;Ribera, Josep-Maria
通讯作者:
Ribera, Josep-Maria
影响因子:
--
作者:
Fatorova I;Blaha M;Lanska M;Vokurkova D;Rezacova V;Zak P
通讯作者:
Zak P